115 related articles for article (PubMed ID: 7453846)
41. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
[TBL] [Abstract][Full Text] [Related]
42. [Experimental study of the anti-tumoral activity of some azotyperites with N-benzoyl asparagic acid derivative support].
Budeanu CH; Sunel V; Iancu I; Dăneţ D; Dăneţ R
Rev Med Chir Soc Med Nat Iasi; 1973; 77(4):817-23. PubMed ID: 4781132
[No Abstract] [Full Text] [Related]
43. [On the antitumor activity of sigma, N1N-bis(beta-chlorethyl)-L-lysine (lysepsis)].
Snasskaia IG; Larionov LF
Vopr Onkol; 1966; 12(9):66-70. PubMed ID: 6004071
[No Abstract] [Full Text] [Related]
44. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
45. 5-N-Substituted-2-(substituted benzenesulphonyl) glutamines as antitumor agents. Part II: synthesis, biological activity and QSAR study.
Samanta S; Srikanth K; Banerjee S; Debnath B; Gayen S; Jha T
Bioorg Med Chem; 2004 Mar; 12(6):1413-23. PubMed ID: 15018914
[TBL] [Abstract][Full Text] [Related]
46. Morphometric and kinetic analysis of the growth of experimental sarcoma-45 in the presence of Ukrain.
Deneka ER
Drugs Exp Clin Res; 1998; 24(5-6):281-5. PubMed ID: 10190088
[TBL] [Abstract][Full Text] [Related]
47. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
48. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
[TBL] [Abstract][Full Text] [Related]
49. Hybrid aza-steroid alkylators in the treatment of colon cancer.
Trafalis DT
Cancer Lett; 2006 Nov; 243(2):202-10. PubMed ID: 16412564
[TBL] [Abstract][Full Text] [Related]
50. The in vitro antitumor assay of "half-mustard type" phenothiazines in screens of AIDS-related leukemia and lymphomas.
Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Molnár J
Anticancer Res; 1997; 17(5A):3425-9. PubMed ID: 9413181
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation.
Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L
J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793
[TBL] [Abstract][Full Text] [Related]
52. Structure-activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer.
Suzuki T; Fukazawa N; San-nohe K; Sato W; Yano O; Tsuruo T
J Med Chem; 1997 Jun; 40(13):2047-52. PubMed ID: 9207946
[TBL] [Abstract][Full Text] [Related]
53. Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis.
Faretta M; Bergamaschi D; Ronzoni S; D'Incalci M; Erba E
Eur J Histochem; 1997; 41 Suppl 2():73-4. PubMed ID: 9859790
[No Abstract] [Full Text] [Related]
54. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy.
Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA
J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560
[TBL] [Abstract][Full Text] [Related]
55. Nitroimidazole-based "extruded mustards' designed as reductively activated hypoxia-selective cytotoxins.
Hay MP; Denny WA; Wilson WR
Anticancer Drug Des; 1996 Jul; 11(5):383-402. PubMed ID: 8765531
[TBL] [Abstract][Full Text] [Related]
56. [Structure-activity relationship of hexamethylmelamine derivatives].
Su YZ; Pan QC; Sun MZ; Ren YF
Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):276-80. PubMed ID: 6230876
[No Abstract] [Full Text] [Related]
57. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
58. Effects of nitrogen mustards on the incorporation of amino acids into the proteins of tissues of tumor-bearing rats. I. Amino acid mustards and HN2.
NYHAN WL
J Pharmacol Exp Ther; 1960 Nov; 130():268-74. PubMed ID: 13729970
[No Abstract] [Full Text] [Related]
59. Synthesis of aromatic nitrogen mustard agents and analysis of their alkylation activity at physiological pH and temperature.
Bartzatt R; Kasher L
Physiol Chem Phys Med NMR; 2002; 34(2):103-17. PubMed ID: 12841328
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage.
Kapuriya N; Kapuriya K; Zhang X; Chou TC; Kakadiya R; Wu YT; Tsai TH; Chen YT; Lee TC; Shah A; Naliapara Y; Su TL
Bioorg Med Chem; 2008 May; 16(10):5413-23. PubMed ID: 18450456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
